HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions

American Journal of Surgical Pathology

Volumn 32, Issue 2, 2008, Pages 236-242

  Mao, Tsui Lien ^a,b   Kurman, Robert J ^a   Jeng, Yung Ming ^b   Huang, Wilber ^c   Shih, Ie Ming ^a,d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Abnova Taiwan Corporation   (Taiwan)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HSD3B1; Trophoblastic tumors and tumorlike lesions

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HYDROXYL DELTA 5 STEROID DEHYDROGENASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CHORIOCARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; HYDROXYL DELTA 5 STEROID DEHYDROGENASE GENE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG CARCINOMA; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PANCREAS CARCINOMA; PLACENTA; SCORING SYSTEM; SYNCYTIOTROPHOBLAST; TROPHOBLAST; TROPHOBLASTIC TUMOR; TUMOR GENE; WESTERN BLOTTING;

3-HYDROXYSTEROID DEHYDROGENASES; ADENOCARCINOMA; ADULT; BLOTTING, WESTERN; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION; HUMANS; MALE; PLACENTA DISEASES; PREGNANCY; TROPHOBLASTIC NEOPLASMS; TROPHOBLASTS; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 38649091991     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31812e0046     Document Type: Article

References (17)

1. Boon K, Osorio EC, Greenhut SF, et al. An anatomy of normal and malignant gene expression. Proc Natl Acad Sci USA. 2002;99:11287-11292.
2. Budwit-Novotny DA, McCarty KS, Cox EB, et al. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 1986;46:5419-5425.
3. Chen Y-C, Pohl G, Wang T-L, et al. Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. Cancer Res. 2005;65:331-337.
4. Lal A, Lash AE, Altschul SF, et al. A public database for gene expression in human cancers. Cancer Res. 1999;59:5403-5407.
5. Lessey BA, Castelbaum AJ, Wolf L, et al. Use of integrins to date the endometrium. Fertil Steril. 2000;73:779-787.
6. Mao TL, Kurman RJ, Huang CC, et al. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol. 2007. In press.
7. McMaster MT, Librach CL, Zhou Y, et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol. 1995;154:3771-3778.
8. Nakayama K, Nakayama N, Davidson B, et al. A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Proc Natl Acad Sci USA. 2006;103:18739-18744.
9. Shih Ie M. Application of human leukocyte antigen-g expression in the diagnosis of human cancer. Hum Immunol. 2007;68:272-276.
10. Shih Ie M. Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Ann Diagn Pathol. 2007;11:228-234.
11. Shih IM. Gestational trophoblastic neoplasms-pathogenesis and target-based therapy. Lancet Oncol. 2007;8:642-650.
12. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20:31-47.
13. Shih IM, Nesbit M, Herlyn M, et al. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Mod Pathol. 1998;11:1098-1106.
14. Simard J, Ricketts ML, Gingras S, et al. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr Rev. 2005;26:525-582.
15. Singer G, Kurman RJ, McMaster M, et al. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol. 2002;26:914-920.
16. Singer G, Rebmann V, Y-C C, et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res. 2003;9:4460-4464.
17. Yen MJ, Hsu CY, Mao TL, et al. Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma. Clin Cancer Res. 2006;12:827-831.